This policy brief explores the dangerous potential of neuroweapons, the need for a “Neuroshield” to protect democracies from the risks of disinformation, the implications of brain-computer interfaces and other national security considerations related to brain health.
Harris A. Eyre, William Hynes, Geoffrey F. L. Ling, Jo-An Occhipinti, Rym Ayadi, Michael D. Matthews, Ryan Abbott, Patrick LoveAugust 10, 2023
Expanding current non-immigrant work permit categories through minimal adjustments is a way to move forward on immigration reform — one that recognizes the undocumented community for its valuable contributions, writes expert Catherine Glazer in a new policy brief for the Center for the United States and Mexico.
The human papillomavirus (HPV) affects over 80 million Americans, causing more than 40,000 cases of HPV-associated cancers in the U.S. In 2006, the FDA licensed the first HPV vaccine, which could help save thousands of lives; no cure for HPV currently exists. However, the political controversy raised by the vaccine has limited its acceptance and use. Such resistance potentially jeopardizes an opportunity to reduce cancer rates in Texas and the broader United States.
Kirstin R.W. Matthews, Monica M. MatsumotoOctober 6, 2014